| May 1 |
Allergan Comments on Today's Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency's Safety Review of Botulinum Toxins |
| May 1 |
SDI Reports: Antiviral Prescriptions Increased Nearly Nine-Fold on Tuesday, April 28 |
| May 1 |
EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus |
| May 1 |
Allergan Reports First Quarter 2009 Operating Results |
| May 1 |
Amylin Sends Letter to Shareholders |
| May 4 |
FDA, FTC Warn Public of Fraudulent 2009 H1N1 Influenza Products |
| May 4 |
New Survey Shows the Difficulty of Developing Effective Flu Vaccines |
| May 4 |
Roche Rapidly Responds to WHO Request to Deploy Rapid Response Stockpiles of Tamiflu to Tackle Global Emergence of a New H1N1 Influenza A Strain - Swine Flu |
| May 4 |
Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules in the U.S. |
| May 4 |
Acadia Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America |
| May 4 |
SDI Reports: Sixty-Seven Percent Of Physicians Surveyed Have Positive Attitude Toward Electronic Promotional Activities |
| May 4 |
Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market |
| May 4 |
Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer |
| May 5 |
Teva Reports First Quarter 2009 Results |
| May 5 |
Bio-Imaging Technologies to Acquire etrials Worldwide |
| May 5 |
Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young |
| May 5 |
SDI Reports: amid Swine Flu Fears, New Antiviral Prescriptions Increase over 19 Times in 1 Week |
| May 5 |
Sanofi-aventis Converts Its Vitry-sur-Seine Industrial Facility to Biotechnologies |
| May 5 |
Health Affairs Thematic Issue On Mental Health Care Explores U.S. Mental Health Care Trends, Comparative Effectiveness, Access For Veterans, And Supported Employment |
| May 5 |
MedWatch - Antiepileptic Drugs:FDA Updated Labeling to Warn About Increased Risk of Suicidal Thoughts and Behaviors |
| May 5 |
Evotec to Re-engineer Drug Discovery and Development Operations |
| May 6 |
FDA Issues an Update about Suicidal Behavior and Ideation and Antiepileptic Drugs |
| May 6 |
Orion Corporation (FI) - Orion reacquires rights for i.v. levosimendan (Simdax) |
| May 6 |
Neurocrine Announces Work Force Restructuring |
| May 6 |
GlaxoSmithKline to Divest US Rights for Wellbutrin XL to Biovail for $510 Million |
| May 7 |
U.S. FDA Licenses Sanofi Pasteur's New Influenza Vaccine Manufacturing Facility |
| May 7 |
Proton Pump Inhibitors Interfere With Anti-Clotting Protection of Clopidogrel |
| May 7 |
Takeda to Integrate Its Two Manufacturing Operations in Ireland |
| May 7 |
Takeda to Start Sales and Marketing Operation in Portugal |
| May 7 |
MedWatch - Testosterone gel products: Boxed warning required to inform users of risk of unintended secondary exposure of children to testosterone |
| May 7 |
Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 |
| May 7 |
Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists in the Field of Autoimmune Diseases |
| May 7 |
Statement From Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005 |
| May 8 |
President's FY 2010 Budget for FDA Invests Substantially in Food and Medical Product Safety |
| May 8 |
Ardea Biosciences Reports Recent Accomplishments and First Quarter 2009 Financial Results |
| May 8 |
European Medicines Agency Recommendations On Extension Of Shelf Life For Tamiflu |
| May 11 |
SDI Reports: Promotional Expenditures Flatten as the Number of Branded Blockbuster Drugs Decreases |
| May 11 |
Warner Chilcott Proposes Redomestication From Bermuda to Ireland |
| May 11 |
MedWatch - Tarceva (erlotinib):Dear HCP letter issued to warn about GI perforation, exfoliative skin conditions and corneal perforation/ulceration |
| May 11 |
Northfield Effectuates Plant Closing |
| May 11 |
King Pharmaceuticals Reports First-Quarter 2009 Financial Results |
| May 11 |
Teikoku Pharma USA Acquires Travanti Pharma Inc. |
| May 11 |
Vermont Enacts Sweeping Gift Ban; Affects Drug, Device, Biologics Manufacturers |
| May 11 |
Regarding the Statement in Pfizer’s 10-Q Report Dated May 8th, 2009 |
| May 11 |
Merck Statement on California Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Vioxx Costs |
| May 11 |
PhRMA Statement on Healthcare Reform Coalition |
| May 12 |
Teijin Pharma Licenses Marketing Rights of TMX-67 in Taiwan to Astellas Pharma Taiwan for Treatment of Hyperuricemia in Patients with Gout |
| May 12 |
GSK Extends Strategic Collaboration with Aspen |
| May 12 |
Small Promotional Items from Drug Companies May Influence Medical Students' Attitudes |
| May 12 |
Roche provides additional donation of 5.65 million packs of Tamiflu to World Health Organization |
| May 12 |
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment |
| May 12 |
Growth in Drug Sales of the Top 10 Pharmaceutical Companies Slowed to its Lowest Level in Years in 2008 |
| May 12 |
FDA Sends Warning Letter to General Mills Over Cereal Claims |
| May 12 |
Cegedim Dendrite Releases Results of 2009 Direct-to-Consumer Marketing Survey |
| May 14 |
Most Americans Would Consider Splitting Pills to Save Money If Medicine Remains Safe and Effective, Survey Shows |
| May 14 |
Icahn Issues Open Letter to Amylin Shareholders |
| May 14 |
FDA Sends Sanofi-Aventis Letter Regarding Taxotere Promotion |
| May 15 |
GlaxoSmithKline Update: A (H1N1) Influenza Vaccine Development |
| May 15 |
President Obama Appoints Dr. Thomas Frieden as CDC Director |
| May 15 |
Sanofi-aventis Introduces Sanofi-aventis TV |
| May 15 |
Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses |
| May 18 |
Daiichi Sankyo and MorphoSys Expand Collaboration with Two New Cancer-Related Antibody Programs |
| May 18 |
Cimzia(certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease |
| May 18 |
Takeda to Acquire IDM Pharma, Adding MEPACT (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise |
| May 18 |
Watson Provides Update on Ferrlecit Supply and Distribution Agreement |
| May 18 |
A Small Number of Bottles of the Antibiotic Rofact (Rifampin) May Contain a Different Drug |
| May 18 |
AstraZeneca Announces Toprol-XL (Metoprolol Succinate) is Now Available |
| May 19 |
U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth |
| May 19 |
The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure |
| May 19 |
Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans |
| May 19 |
Onyx Pharmaceuticals Files Complaint Against Bayer Corporation |
| May 19 |
"Innovative Medicine Initiative" (IMI): €246 Million to Support Public-Private Research Cooperation for a Fast Development of Better Medicines |
| May 19 |
Sebelius Congratulates New FDA Commissioner Peggy Hamburg |
| May 20 |
Bio-Imaging Technologies Increases Its Offer to Acquire etrials Worldwide |
| May 20 |
moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico |
| May 20 |
Sandoz to Acquire EBEWE Pharma Specialty Generics Business, Improving Access for Patients Worldwide to Injectable Cancer Drugs |
| May 20 |
Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide |
| May 20 |
FDA Sends Warning Letter to Johnson & Johnson Regarding Consumer Webcast Video |
| May 20 |
FDA Sends Warning Letter to Cornerstone Therapeutics Regarding Sales Aids |
| May 20 |
Medication Used to Treat Urination Difficulties for Men Associated With Higher Risk of Ophthalmic Complications Following Cataract Surgery |
| May 21 |
FDA Updates Information for Tamiflu: Dosing Recommendations for Infants and Technical Documents |
| May 21 |
Schering-Plough, Merck Address J&J Remicade Agreement in SEC Filing |
| May 21 |
Pharmalive.Com and Mx Magazine Launch New Leadership Report Focusing On The Medical-Technology Industry |
| May 22 |
Blood Pressure Lowering Drugs Should Not Be Limited to People With High Blood Pressure |
| May 22 |
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc. |
| May 22 |
Dr. Reddy's Receives Approval for Three INDs and Announces Reorganization of Its Drug Discovery Operations |
| May 22 |
Aastrom Proactively Places Phase II IMPACT-DCM Clinical Trial On Hold Following Report of Serious Adverse Event |
| May 26 |
Daiichi Sankyo and Ranbaxy Announce Reconstitution of Ranbaxy Executive Leadership |
| May 26 |
Biogen Idec Sends Letter to Stockholders |
| May 27 |
Metabasis Therapeutics Announces Corporate Restructuring and Notice of Noncompliance with Nasdaq Listing Requirements |
| May 27 |
In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always “Good Medicine” |
| May 27 |
New NICE Guideline For Type 2 Diabetes Recognises Benefits From Newer Agents For Blood Glucose Control |
| May 27 |
Ignoring Insomnia Costs America $42 Billion a Year |
| May 27 |
Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? |
| May 28 |
Schering-Plough and Merck Provide Update on Distribution Agreement |
| May 28 |
Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for Remicade and Simponi |
| May 28 |
CSL Limited Responds to FTC Announcement |
| May 28 |
Boehringer Ingelheim helps families hit hardest by economy: national emerging trend study |
| May 28 |
Novartis International AG (CH) - Novartis Increases Its Offer Price on Novartis India Ltd. |
| May 28 |
FTC Authorizes Suit To Stop CSL’s Proposed $3.1 Billion Acquisition of Talecris Biotherapeutics |
| May 28 |
Talecris Responds to U.S. Federal Trade Commission Filing of Complaint to Challenge Proposed CSL Transaction |
| May 28 |
Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations |
| May 28 |
Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists |
| May 28 |
Genentech tops MSImage study of oncologists, hemotologists |
| May 28 |
PwC Report: Biologics Sector to Drive Biopharma Deal Activity Remainder of 09 |
| May 28 |
Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation |
| May 29 |
CSL reaffirms its commitment to supply Australia with Novel Influenza A (H1N1) ‘Swine Flu’ Vaccine |
| May 29 |
FDA MedWatch - Simponi (golimumab)-Risk of Serious Fungal Infections Associated With TNF-álpha Blockers, Including Simponi |
| May 29 |
A.P. Pharma Announces Additional Restructuring Effort |
| May 29 |
European Medicines Agency Recommends Lifting Of Supply And Treatment Restrictions for Neupro |
| May 29 |
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation |
| May 29 |
Mylan Receives Tentative FDA Approval for Generic Version of Singulair |
| May 29 |
Dey L.P. to Market EMSAM Skin Patch for Treatment of Major Depressive Disorder |
| May 29 |
Sucampo Board of Directors Issues Statement Regarding Sales Performance by Takeda Pharmaceuticals North America for Amitiza |
| May 29 |
New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment |
| May 29 |
New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance |
| May 29 |
Pfizer's Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency |
| May 29 |
MSL360o Launches LEARN Training Programs and Appoints Dr. Michael T. Cullen as Chief Medical Officer |
